Clinical Trials Logo
  1. Home
  2. Pregnancy
  3. NCT02125149
  4. Details
NCT02125149 Clinical Trial

The Expecting Study

Pregnancy Clinical Trial

Official title:
Prenatal Physical Activity Intervention

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number NCT02125149
Other study ID # 202954
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date September 2, 2014
Est. completion date October 31, 2024

Study information
Verified date February 2024
Source Arkansas Children's Hospital Research Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to determine how a mother's health and physical activity may influence her child's growth and development.

Recruitment information / eligibility
Status Active, not recruiting
Enrollment 284
Est. completion date October 31, 2024
Est. primary completion date October 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - BMI >30 - >18 years of age - Singleton pregnancy - Less than 12 weeks gestation - Sedentary - Conceived without assisted fertility treatments - Cleared by physician to exercise Exclusion Criteria: - Women with pre-existing medical conditions as determined by the PI to affect the outcomes of interest - Women who are using recreational drugs, tobacco, or alcohol during pregnancy - Women with contraindications to exercise during pregnancy

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Exercise Intervention

Locations
Country Name City State
United States Tonja C Nolen Conway Arkansas

Sponsors (1)
Lead Sponsor Collaborator
Arkansas Children's Hospital Research Institute

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Risk of obesity in infants and children Birth weight, body fat, and metabolism will be evaluated during the first 2 years of life. 2 years
Secondary Maternal insulin sensitivity Fasted blood samples will be analyzed to assess glucose and insulin. 9 months
Secondary Maternal inflammation Markers of inflammation will be investigated in fasted serum samples. 9 months
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Completed NCT02408315 - Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE) Phase 3